Brief: Bharat Parenterals Says Unit Out-Licenses Two Molecules To Generic Pharma MNCs
21/11/2024 09:21
Nov 21 (Reuters) - Bharat Parenterals Ltd BATP.BO :
* UNIT OUT-LICENSES TWO MOLECULES TO GENERIC PHARMA MNCS
Source text: ID:nBSEbFrQh2
Further company coverage: BATP.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bharat Parenterals
See all newsBrief: Bharat Parenterals Says U.S. FDA Conducts Surprise Inspection At Innoxel Lifesciences Vadodara Facility
India's Bharat Parenteral rebounds on successful completion of EU GMP inspection
Brief: Bharat Parenterals Says Innoxel Lifesciences Completes EU GMP Inspection By Belgium's FAMHP
India's Bharat Parenterals jump after unit clears US FDA inspection
Brief: Bharat Parenterals Secures $27 Mln Order For Pharmaceutical Products